Health
Australia signs agreement for new Covid-19 drug – Pharmaceutical Business Review
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths…
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths and hospitalisations due to Covid-19.
Being trialled in the US, this drug is yet to gain approval from the regulatory authorities.
…
Continue Reading
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General23 hours agoWhy do states and territories have different school holidays?
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025